Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tax incentive for Australian research and development.

M Andrew

    Australasian Biotechnology
    |October 1, 1991
    PubMed
    Summary

    Successful research and development (R&D) in biotechnology offers significant commercial rewards. Companies should explore R&D tax concessions to reduce project costs and gain a competitive edge in this dynamic global industry.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of genetic modifiers of somatic CAG instability in Huntington's Disease by in vivo CRISPR - Cas9 genome editing: <b>PS238</b>.

    Porto biomedical journal·2020
    Same author

    Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

    Journal of medical microbiology·2019
    Same author

    First Report of Alternaria Brown Spot of Citrus Caused by Alternaria alternata in Peru.

    Plant disease·2019
    Same author

    Antivibration gloves: effects on vascular and sensorineural function, an animal model.

    Journal of toxicology and environmental health. Part A·2015
    Same author

    Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
    Same author

    Rabbit Platelets do not Express Fc Receptors for IgG.

    Platelets·2010

    Area of Science:

    • Biotechnology
    • Innovation Management
    • Taxation Law

    Background:

    • The biotechnology sector thrives on innovation, necessitating continuous advancements for competitive advantage.
    • Commercial success from research and development (R&D) is a key driver for investment in biotechnology.
    • The global biotechnology landscape is dynamic, demanding constant strategic adaptation.

    Purpose of the Study:

    • To highlight the financial benefits of R&D tax concessions for biotechnology companies.
    • To encourage strategic consideration of R&D tax incentives for competitive advantage.
    • To inform companies about the availability and eligibility criteria for R&D tax concessions.

    Main Methods:

    • Analysis of the relationship between R&D investment and commercial rewards in biotechnology.
    • Examination of the role of R&D tax concessions in cost reduction for eligible projects.
    • Review of factors influencing competitive advantage in the global biotechnology market.

    Main Results:

    • R&D tax concessions can offer substantial cost savings for qualifying biotechnology projects.
    • Strategic utilization of R&D tax incentives can enhance a company's competitive position.
    • Understanding eligibility and availability of tax concessions is crucial for financial planning.

    Conclusions:

    • Biotechnology firms should actively investigate R&D tax concessions to optimize investment returns.
    • Leveraging R&D tax benefits is essential for maintaining competitiveness in the fast-evolving biotechnology industry.
    • Eligibility assessment for R&D tax concessions is a critical step for cost-effective project development.

    Related Experiment Videos